These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 227565

  • 1. Interaction of factors associated with cancer of the nasopharynx.
    Lin TM, Yang CS, Tu SM, Chen CJ, Kuo KC, Hirayama T.
    Cancer; 1979 Oct; 44(4):1419-23. PubMed ID: 227565
    [Abstract] [Full Text] [Related]

  • 2. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma.
    Hildesheim A, West S, DeVeyra E, De Guzman MF, Jurado A, Jones C, Imai J, Hinuma Y.
    Cancer Res; 1992 Jun 01; 52(11):3048-51. PubMed ID: 1317256
    [Abstract] [Full Text] [Related]

  • 3. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency.
    Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, Liu MY.
    Anticancer Res; 1990 Jun 01; 10(2B):547-53. PubMed ID: 2161639
    [Abstract] [Full Text] [Related]

  • 4. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
    Hsu WL, Chen JY, Chien YC, Liu MY, You SL, Hsu MM, Yang CS, Chen CJ.
    Cancer Epidemiol Biomarkers Prev; 2009 Apr 01; 18(4):1218-26. PubMed ID: 19336547
    [Abstract] [Full Text] [Related]

  • 5. Selected observations on the epidemiology of pharyngeal cancers.
    Louie E, Henderson BE, Buell P, Jing JS, Menck HR, Pike MC.
    Natl Cancer Inst Monogr; 1977 Dec 01; 47():129-33. PubMed ID: 206840
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Dec 01; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 7. Seroepidemiological studies on carcinoma of the nasopharynx.
    Lin TM, Yang CS, Chiou JF, Tu SM, Lin CC, Liu CH, Chen KP, Ito Y, Kawamura A, Hirayama T.
    Cancer Res; 1973 Nov 01; 33(11):2603-8. PubMed ID: 4355974
    [No Abstract] [Full Text] [Related]

  • 8. The Chinese epidemiological approach of nasopharyngeal carcinoma research and control.
    De-Thé G.
    Yale J Biol Med; 1981 Nov 01; 54(1):33-9. PubMed ID: 6264696
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for nasopharyngeal carcinoma.
    Lin TM, Chang HJ, Chen CJ, Cheng YJ, Yang CS, Tu SM, Ito Y, Kawamura A, Hirayama T.
    Anticancer Res; 1986 Nov 01; 6(4):791-6. PubMed ID: 3752958
    [Abstract] [Full Text] [Related]

  • 10. [Epstein-Barr virus (EBV) infection associated with nasopharyngeal carcinoma].
    Furukawa M.
    Gan To Kagaku Ryoho; 1990 Apr 01; 17(4 Pt 1):601-7. PubMed ID: 2157366
    [Abstract] [Full Text] [Related]

  • 11. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
    Ruiz R, Gurtsevich V, Le Riverend E.
    Neoplasma; 1979 Apr 01; 26(2):125-31. PubMed ID: 224330
    [Abstract] [Full Text] [Related]

  • 12. Histopathological types of nasopharyngeal carcinoma in a low-risk area: Japan.
    Sugano H, Sakamoto G, Sawaki S, Hirayama T.
    IARC Sci Publ (1971); 1978 Apr 01; (20):27-39. PubMed ID: 215515
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups.
    Lin TM, Yang CS, Chiou JF, Tu SM, Chen TY, Tu YC, Lin PJ, Kawamura A, Hirayama T.
    Am J Epidemiol; 1977 Oct 01; 106(4):336-9. PubMed ID: 199059
    [Abstract] [Full Text] [Related]

  • 14. Lack of association between cigarette smoking and Epstein Barr virus reactivation in the nasopharynx in people with elevated EBV IgA antibody titres.
    Chen Y, Xu Y, Zhao W, Xiao X, Zhou X, Lin L, Huang T, Liao J, Li Y, Zeng X, Huang G, Ye W, Zhang Z.
    BMC Cancer; 2018 Feb 14; 18(1):190. PubMed ID: 29444646
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
    Coghill AE, Wang CP, Verkuijilen SAWM, Yu KJ, Hsu WL, Middeldorp JM, Hildesheim A.
    J Med Virol; 2018 Jan 14; 90(1):191-195. PubMed ID: 28833336
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma and other neoplastic conditions.
    Kottaridis SD, Dafnou M, Besbeas S, Garas J.
    J Natl Cancer Inst; 1977 Jul 14; 59(1):89-91. PubMed ID: 195074
    [Abstract] [Full Text] [Related]

  • 18. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong.
    Lo S, Ho WK, Wei WI.
    Arch Otolaryngol Head Neck Surg; 2004 Jun 14; 130(6):770-2. PubMed ID: 15210561
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus seroepidemiology in China.
    Zeng Y, Pi GH, Deng H, Zhang JM, Wang PC, Wolf H, De Thé G.
    AIDS Res; 1986 Dec 14; 2 Suppl 1():S7-15. PubMed ID: 3030349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.